City of Hope Opens Oncolytic Virus Clinical Trial for Patients With Advanced Breast Cancer

DUARTE, Calif.--(BUSINESS WIRE)--City of Hope, a world-renowned research and treatment organization for cancer, diabetes and other life-threatening diseases, today announced the opening of a first-in-human clinical trial evaluating the use of a cancer-killing oncolytic virus to treat patients with metastatic triple-negative breast cancer. The City of Hope-developed therapy, CF33-hNIS-antiPDL1, is...

Click to view original post